OpenAI-backed Chai Discovery raises $130M Series B at $1.3B valuation; AI drug startup to build computer-aided molecular design suite three months after last funding round

OpenAI-Backed Chai Discovery Raises $130 Million for AI-Designed Molecules

Chai Discovery, an artificial intelligence drug-discovery company backed by OpenAI, has raised $130 million to build a “computer-aided design suite” for molecules.The deal, which values the company at $1.3 billion, comes just three months after the startup’s last funding round and brings its total financing to $225 million. The Series B financing was co-led by Oak HC/FT and General Catalyst....